Caristo Diagnostics Named Quarterfinalist in Digital Health Awards
Caristo Diagnostics, a leading company in cardiovascular disease diagnostics, has achieved quarterfinalist status in the prestigious Digital Health Hub Foundation: Digital Health Awards. This recognition is specifically for the Rising Star Provider Diagnostics category.
Commitment to Innovation
This accolade highlights Caristo's dedication to transforming heart disease management by focusing on hidden inflammation, a critical factor in preventing heart attacks. The Digital Health Awards honor organizations like Caristo that strive to improve healthcare systems through cutting-edge digital technologies. As a notable quarterfinalist, Caristo demonstrates a strong commitment to utilizing advanced artificial intelligence to diagnose cardiovascular issues, helping healthcare professionals more effectively assess and treat coronary artery disease, which remains the leading cause of death globally.
CEO's Thoughts on the Recognition
Frank Cheng, the CEO of Caristo Diagnostics, shared his appreciation for the honor, stating, "We are truly grateful to be recognized as a quarterfinalist in the Provider Diagnostics category of the Digital Health Awards. This achievement reflects our continuous efforts to improve heart health and the positive outcomes our clients experience through our innovative technologies."
Standing Out in a Competitive Field
The competition was intense, with over 1,500 entries submitted, and only 15 quarterfinalists selected in each category. This rigorous selection process highlights the remarkable talent and innovation present in the digital health landscape.
Scientific Validation and Technology Accessibility
Recent research published in The Lancet reveals the shortcomings of current diagnostics that focus solely on obstructive coronary artery disease, noting that they miss two-thirds of significant cardiac events. Caristo's unique technology, CaRi-Heart, measures coronary inflammation, allowing it to detect this hidden yet treatable aspect of disease progression.
Availability of CaRi-Heart Technology
At present, CaRi-Heart technology is available in the European Union, the United Kingdom, and Australia. The team is also working towards obtaining clearance from the US Food & Drug Administration to broaden its reach.
Insights from the Digital Health Hub Foundation
Mark Goldstein, Chairman of the Digital Health Hub Foundation, commented, "This year has set a new standard for excellence, showcasing an impressive range of global submissions that highlight extraordinary innovations in digital health. The creativity and dedication displayed are truly inspiring. Congratulations to all our quarterfinalists for their remarkable achievements."
Looking Forward: Announcements of Finalists and Winners
The finalists for the awards will be announced soon, with winners set to be revealed during the Grand Finale at HLTH. Excitement is building as the healthcare community eagerly anticipates the recognition of the most impactful innovations in digital health.
About Caristo Diagnostics
Caristo Diagnostics is a pioneer in diagnostics for cardiac and vascular diseases. Founded in 2018 as a spin-off from the University of Oxford, Caristo has developed a suite of imaging-based and AI-enhanced platforms designed to predict and diagnose heart attacks, strokes, and diabetes. The company has been recognized by Newsweek as one of the top digital health companies and acknowledged by Nature as one of the most exciting science-based ventures emerging from academic research. You can connect with Caristo through its website, LinkedIn, and X.
About Digital Health Hub Foundation
The Digital Health Hub Foundation is dedicated to empowering innovative healthcare companies to scale effectively. Established in 2017 on the UCSF campus, this community now encompasses 30,000 members, including healthcare companies at various stages, providers, payers, and industry experts, who gather for an annual awards ceremony to celebrate achievements in healthcare technology.
Contact Information
For inquiries, please contact Frank Cheng, CEO of Caristo Diagnostics, at [email protected].
Frequently Asked Questions
What are the Digital Health Awards?
The Digital Health Awards recognize organizations that enhance healthcare through innovative digital technologies and solutions.
What technology does Caristo Diagnostics utilize?
Caristo employs its proprietary CaRi-Heart technology to assess coronary inflammation, which assists in diagnosing cardiovascular diseases.
Where can I find Caristo's technology?
CaRi-Heart technology is currently available in the EU, the UK, and Australia, with plans to expand into the US market.
Who is the CEO of Caristo Diagnostics?
Frank Cheng is the CEO of Caristo Diagnostics, and he has expressed appreciation for the company's recognition in the Digital Health Awards.
When will the finalists and winners be announced?
The finalists will be announced soon, with winners expected to be revealed during the Grand Finale event at HLTH shortly thereafter.